XOMA Royalty Corp. (XOMA) Financials

XOMA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 271.9 million 159.0 million
Dec. 31, 2025 272.7 million 168.7 million
Sept. 30, 2025 263.2 million 155.2 million
June 30, 2025 223.5 million 131.0 million

XOMA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 6.0 million 2.3 million
Dec. 31, 2025 -5.5 million 3.9 million
Sept. 30, 2025 -296000 1.8 million
June 30, 2025 6.4 million 1.6 million

XOMA Net Income

No data available :(

XOMA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 95.0 million 88.8 million 19.5 million
Dec. 31, 2025 82.9 million 96.5 million 20.1 million
Sept. 30, 2025 92.0 million 94.4 million 20.7 million
June 30, 2025 83.9 million 102.2 million 710000

XOMA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 17.4 million
Dec. 31, 2025 18.1 million
Sept. 30, 2025 18.1 million
June 30, 2025 17.8 million

XOMA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 49000 11.9 million -
Dec. 31, 2025 - 281000 10.4 million -
Sept. 30, 2025 111000 69000 9.7 million -
June 30, 2025 - 69000 7.8 million -3000

XOMA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 12.3 million 895000
Dec. 31, 2025 1.4 million 884000
Sept. 30, 2025 9.4 million 878000
June 30, 2025 13.1 million 658000

XOMA

Price: $41.97

52 week price:
22.29
42.81

Dividend Yield: 5.18%

Payout Ratio Range:
-60.00%
57.79%

Earnings Per Share: 1.57 USD

P/E Ratio: 26.53

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 14100

Ebitda: 28.3 million

Market Capitalization: 522.8 million

Links: